VGXP XP E1 TIB BRG RL 10X71
Report
- Report Number
- 0001825034-2017-10881
- Event Type
- Injury
- Date Received
- February 19, 2018
- Date of Event
- April 3, 2014
- Report Date
- February 19, 2018
- Manufacturer
- ZIMMER BIOMET, INC.
- Product Code
- MBH
- PMA / PMN Number
- PK122160
- Removal / Correction Number
- N/A
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- PHYSICIAN
Narratives
ZIMMER BIOMET COMPLAINT- (B)(4). CONCOMITANT MEDICAL PRODUCTS: PART 195203, LOT 503670- VGXP INTLK FMRL RT 60, PART 195251, LOT 936260- VNGD XP INLK PRI TIB TRAY 75MM, PART 195333, LOT 867980 - VGXP XP E1 TIB BRG RL 10X71, PART 195402, LOT 868540- VGXP XP E1 TIB BRG RM 9X71. CUSTOMER HAS INDICATED THAT THE PRODUCT WILL NOT BE RETURNED TO ZIMMER BIOMET FOR INVESTIGATION. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT; PLEASE SEE ASSOCIATED REPORTS: MFR 0001825034-2018-10875, MFR 0001825034-2018-10876, MFR 0001825034-2018-10881, MFR 0001825034-2018-10882. REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. DHR WAS REVIEWED AND NO DISCREPANCIES RELATED TO THIS COMPLAINT WERE FOUND. REVIEW OF THE COMPLAINT HISTORY DETERMINED THAT NO FURTHER ACTION IS REQUIRED AS NO TRENDS WERE IDENTIFIED. ROOT CAUSE WAS UNABLE TO BE DETERMINED. THERE ARE WARNINGS IN THE PACKAGE INSERT THAT THIS TYPE OF EVENT CAN OCCUR AND RISKS ARE ADDRESSED IN RISK DOCUMENTATION. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS. THIS REPORT IS BEING SUBMITTED LATE AS IT HAS BEEN IDENTIFIED IN REMEDIATION.
PAIN AND DISCOMFORT 6 MONTHS AND 1 YEAR POST A TOTAL KNEE ARTHROPLASTY PROCEDURE ON THE RIGHT KNEE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 123184 | VGXP XP E1 TIB BRG RL 10X71 | PROSTHESIS,KNEE | MBH | ZIMMER BIOMET, INC. | N/A | 867980 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 67 YR | Other |